Release Date: 04/11/22 15:28 Summary: Units on Issue Disclosure - October 2022 Price Sensitive: No Download Document 116.06KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%